This site is intended for UK healthcare professionals
Medscape UK Univadis Logo
Medscape UK Univadis Logo
More from medscape

News

New Monkeypox Guidance for Health Professionals

The UK's four public health agencies have issued new guidance on how healthcare professionals should address cases of monkeypox.

It marks a shift from a "highly precautionary" response designed to contain the outbreak around a few isolated cases, to suppressing transmission with the aim of eventual eradication.

The document, Principles for monkeypox control in the UK: 4 nations consensus statement, calls for a "proportionate response to deliver on achievable strategic outcomes" now that community transmission is occurring. It also calls for an emphasis on protecting against the disease spreading in hospitals and healthcare settings and to healthcare workers, and ensuring safe functioning of NHS services.

Targeted Health Response

The transition from treating the monkeypox outbreak under a high consequence infectious disease management system to one of targeted public health measures aimed at stifling its spread, has been aided by the availability of pre- and post-exposure prophylaxis using the vaccinia Ankara (MVA-BN) vaccine (Imvanex, Bavarian Nordic). The UK Health Security Agency (UKHSA) simultaneously updated its guidance on using the MVA-BN smallpox vaccine, sanctioning its use for pre- and post-exposure to the monkeypox virus.

The public health agencies agreed that the change to handling the outbreak in the UK was also helped by rapid molecular testing establishing that all the UK cases to date have been of the West African clade of the disease, which carries a 1% mortality rate, and not the Central African clade, which has a much higher mortality rate of 10%.

The health agencies said that adopting an "overly precautionary response" to the outbreak created a public health risk, and that it was vital to ensure affected individuals avoided being stigmatised and engaged with health services if the spread was to be controlled.

Personal Protective Equipment

The guidance also outlines the minimum PPE for healthcare professionals who work with confirmed or probable cases of monkeypox. These are:

  • Gloves
  • Fluid repellent surgical facemask (FRSM) (an FRSM should be replaced with an FFP3 respirator and eye protection if the case presents with a lower respiratory tract infection with a cough and / or changes on their chest x-ray indicating lower respiratory tract infection)
  • Apron
  • Eye protection if there is a risk of splash to the face and eyes

For confirmed cases requiring ongoing clinical management, the minimum recommended PPE for healthcare workers is:

  • Fit-tested FFP3 respirator
  • Eye protection
  • Long sleeved, fluid repellent, disposable gown
  • Gloves

Patients with a confirmed diagnosis who are in adult social care, prisons, homeless shelters, refuges, and other non-residential settings, and who are clinically well, should be managed in a single room with separate toilet facilities where possible, and their close contacts assessed for vaccination.

The statement was agreed by the UK Health Security Agency, Public Health Scotland, Public Health Wales, and Public Health Agency Northern Ireland.

Lead Image Credit: Medscape Illustration/Getty Images/Dreamstime

Register Today

Already a member? Log in

YOU MAY ALSO LIKE

Hundreds of GP practices in England will join a new NHS pilot using patient records to spot pancreatic cancer earlier in people at highest risk.
Cardiovascular and autoimmune comorbidities often occur in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease.
Individuals with metabolic dysfunction‐associated steatotic liver disease experience a higher burden of multimorbidity, with a link to increased all-cause mortality, according to a recent study.
A JAMA review has urged earlier recognition and treatment of uveitis, a major cause of preventable blindness, with practical advice for clinicians.
Dr Michael Sproat reviews current guidance from NICE and the BSG on the investigation, diagnosis, and treatment of dyspepsia in primary care
Ian Lowenhoff, Ojas Rajkumar, and Professor Lennard Lee discuss the barriers to oncology research in the UK, and assess how to overcome the challenges
Doctors’ online speech can shape public trust, but should the UK’s General Medical Council regulate what they post on social media?
The development of aortic valve sclerosis may signal disease progression in patients with chronic heart failure.
A retrospective cohort study shows that patients who have a psychiatric history before their diagnosis of autoimmune hypothyroidism are more likely to receive liothyronine.
Continuing metformin throughout the first trimester — rather than stopping it at pregnancy confirmation — may lower the risk for miscarriage and boost live birth rates in women with PCOS.
Radiographers have warned that patients filming NHS treatment for social media risks breaching patient confidentiality and is causing staff anxiety and distraction.
A 55-year-old man presents with alien hand syndrome, his left hand involuntarily opposing every action of his right after an acute splenium stroke.
Patients will be able to find and sign up for clinical trials through the NHS App, as part of a wider plan to boost UK research participation.
A phase 2 AXAGIST trial finds that avelumab combined with axitinib achieves durable disease control in patients with advanced gastrointestinal stromal tumours.
UK researchers are trialling a blood test that could detect pancreatic cancer in its early stages.
A noninvasive ultrasound treatment that destroys liver tumours without surgery or radiation will soon be offered on the NHS in Cambridge in a European first.
A research team at the University of Barcelona shows how allopurinol may prevent aortic aneurysm in Marfan syndrome, paving the way for new clinical trials.